In addition, our comprehensive analysis suggests the basis for future functional analysis that may lead to new potential targets for the treatment of B-ALL, including ID gene family, which has been associated with chemo resistance in different models of cancer. This evidence concerns the gene ID1 and acute lymphoblastic leukemia.